An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2

This article has been Reviewed by the following groups

Read the full article See related articles

Abstract

No abstract available

Article activity feed

  1. SciScore for 10.1101/2020.09.16.300319: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board StatementConsent: Human sera: Control and recovered patient sera were collected from patients through the NYU Vaccine Center with written consent under I.R.B. approval (IRB 20-00595 and IRB 18-02037) and were deidentified.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Sex as a biological variablenot detected.
    Cell Line Authenticationnot detected.

    Table 2: Resources

    Antibodies
    SentencesResources
    Cell-line ACE2 expression levels were quantified by staining with anti-ACE2 antibody (NOVUS) and Alexa-fluor 594-conjugated goat anti-mouse IgG (Biolegend) and pacific blue viability dye.
    anti-ACE2
    suggested: None
    The proteins were analyzed on an immunoblot probed with mouse anti-6XHis antibody (Invitrogen) and horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG secondary antibody (Sigma-Aldrich).
    anti-6XHis
    suggested: None
    anti-mouse IgG
    suggested: None
    The proteins were transferred to polyvinylidene difluoride membranes and probed with anti-HA mAb (Covance), mouse anti-His mAb (Invitrogen) and anti-GAPDH mAb (Life Technologies) followed by goat anti-mouse HRP-conjugated second antibody (Sigma).
    anti-HA
    suggested: None
    anti-His
    suggested: None
    anti-GAPDH
    suggested: None
    anti-mouse
    suggested: None
    The eluted proteins were separated by SDS-PAGE and analyzed on an immunoblot probed with anti-p24 antibody (AG3.0) followed by goat anti-mouse HRP-conjugated second antibody.
    anti-p24
    suggested: None
    Experimental Models: Cell Lines
    SentencesResources
    Cells: Vero E6, CaCO2, A549, ACE2 A549, BHK, Huh7 293T, Vero and CHME3 cells were cultured in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and penicillin/streptomycin (P/S) at 37°C in 5% CO2.
    A549
    suggested: None
    Huh7 293T
    suggested: None
    Vero
    suggested: None
    CHME3
    suggested: ATCC Cat# CRL-3304, RRID:CVCL_II76)
    U937 cells were cultured in RPMI/10% FBS/ with P/S. ExpiCHO-S (Thermo Fisher Scientific) were cultured in ExpiCHO expression medium at 37 °C in 8% CO2.
    U937
    suggested: None
    SARS-CoV-2 pseudotype reporter virus assay: SARS-CoV-2 S protein pseudotyped lentiviral stocks were produced by cotransfecting 293T cells (4 × 106) with pMDL, pLenti.GFP-NLuc, S protein expression vector and pRSV.
    293T
    suggested: None
    The mixture was added to ACE2.293T cells in a 96 well tissue culture dish containing 1 × 104 cells/well.
    ACE2.293T
    suggested: None
    Protein purification and molecular mass determination: 293F cells (Thermo Fisher) at a density of 2.5 × 106 cells/ml were transfected with microbody expression vector plasmid DNA using polyethyleneimine (Polysciences, Inc) at a 1:3 plasmid:PEI ratio.
    293F
    suggested: None
    The infectious virus titer was determined by plaque assay on Vero E6 cells after staining with crystal violet.
    Vero E6
    suggested: RRID:CVCL_XD71)
    Software and Algorithms
    SentencesResources
    Data were analyzed by flow cytometry with Flowjo software.
    Flowjo
    suggested: (FlowJo, RRID:SCR_008520)
    The molecular mass of each protein was determined by analysis with ASTRA 6 software.
    ASTRA
    suggested: (ASTRA, RRID:SCR_016255)
    Data analysis and statistics: All experiments were performed in technical duplicates or triplicates and data were analyzed using GraphPad Prism (Version 7 7.0e).
    GraphPad Prism
    suggested: (GraphPad Prism, RRID:SCR_002798)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: Please consider improving the rainbow (“jet”) colormap(s) used on pages 56 and 53. At least one figure is not accessible to readers with colorblindness and/or is not true to the data, i.e. not perceptually uniform.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.